Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

19.01.2024 - SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select assets from Intermountain ... Seite 1

Related Keywords

Paulj Diaz , ,Intermountain Health System ,Intermountain Healthcare ,Precise Tumor Test ,Solid Tumor ,Precise Liquid ,Myriad Genetics Chart ,Yriad Genetics Kurs ,Yriad Genetics Aktie ,